Home Recalls D-0545-2024
Class II · Moderate risk Completed Initiated May 28, 2024 (2 years ago)
Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
What was recalled
Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,
Recalling firm Winder Laboratories, LLC
NDC code 75826-114-10
Origin GA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0545-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Phenazopyridine recalls
See all
Class II · Moderate risk Terminated May 31, 2024
Reason Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Class II · Moderate risk Terminated Oct 28, 2016
Reason CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Class II · Moderate risk Terminated Oct 28, 2016
Reason CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Class II · Moderate risk Terminated Oct 24, 2016
Reason CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Class II · Moderate risk Terminated Oct 24, 2016
Reason CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures